Depression is a common but serious mood disorder that can affect how a person feels, thinks, and handles their daily activities. It can be a confusing disorder to understand because there are ...
Drug maker Granules India on Friday said it has received approval from the US health regulator to market a generic medication to treat major depressive disorder. The company has received approval from ...
What we're seeing is that this drug has a fairly benign safety profile.” Supernus is aiming to share data from the phase 2b trial, which is testing SPN-820 in treatment-resistant depression (TRD ...
The medication is widely prescribed for the treatment of major depressive disorder and for the prevention of seasonal affective disorder. Granules said it has now a total of 67 ANDA approvals from the ...